Relay Therapeutics (RLAY) Prepaid Assets (2019 - 2026)
Relay Therapeutics (RLAY) posted quarterly Prepaid Assets of $4.6 million for Q1 2026, down 79.22% year-over-year from $22.0 million in Q1 2025, and down 74.35% quarter-over-quarter from $17.8 million in Q4 2025.
Relay Therapeutics (RLAY) Prepaid Assets (2019 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has reported Prepaid Assets for 8 consecutive years, with $4.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 79.22% year-over-year to $4.6 million; the TTM figure through Mar 2026 stood at $4.6 million (down 79.22% YoY), while the FY2025 annual figure was $17.8 million, up 68.87% from the prior year.
- Prepaid Assets declined to $4.6 million in Q1 2026 per RLAY's latest filing, from $17.8 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $22.0 million in Q1 2025 and bottomed at $3.3 million in Q4 2023.
- Historically, Prepaid Assets has averaged $11.0 million across 5 years, with a median of $11.3 million in 2023.
- Annual changes were most pronounced in 2024 — Prepaid Assets jumped 217.74% — and 2025, when it sank 80.01%.
- Relay Therapeutics' Prepaid Assets stood at $12.1 million in 2022, then tumbled by 72.63% to $3.3 million in 2023, then surged by 217.74% to $10.5 million in 2024, then surged by 68.87% to $17.8 million in 2025, then plunged by 74.35% to $4.6 million in 2026.
- Business Quant data shows RLAY's Prepaid Assets at $4.6 million in Q1 2026, $17.8 million in Q4 2025, and $3.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Relay Therapeutics | 4.34 Bn | 4.34 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.74 Mn |
| Mar 31, 2026 | 4.56 Mn |
| Dec 31, 2025 | 17.79 Mn |
| Sep 30, 2025 | 3.74 Mn |
| Jun 30, 2025 | 7.58 Mn |
| Mar 31, 2025 | 21.95 Mn |
| Dec 31, 2024 | 10.53 Mn |
| Sep 30, 2024 | 18.73 Mn |
| Jun 30, 2024 | 10.12 Mn |
| Mar 31, 2024 | 7.30 Mn |
| Dec 31, 2023 | 3.32 Mn |
| Sep 30, 2023 | 17.29 Mn |
| Jun 30, 2023 | 3.39 Mn |
| Mar 31, 2023 | 11.27 Mn |
| Dec 31, 2022 | 12.11 Mn |
| Sep 30, 2022 | 11.58 Mn |
| Jun 30, 2022 | 12.75 Mn |
| Mar 31, 2022 | 12.66 Mn |
| Dec 31, 2021 | 11.47 Mn |
| Sep 30, 2021 | 17.70 Mn |